Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. provides technology, engineering and mission-focused solutions for defense, intelligence, civil, health, commercial and international customers. News about LDOS commonly covers operating results, guidance, dividends, government contract awards, defense systems, digital modernization, health services, air traffic management, autonomous systems and work for U.S. federal agencies.
Company updates also include developments across the National Security & Digital, Health & Civil, Commercial & International and Defense Systems segments, as well as completed acquisitions, material partnerships and production programs such as air and missile defense launchers and secure mission systems.
Leidos (NYSE: LDOS) has secured a prime contract to develop an uncrewed aircraft system (UAS) for the Marine Corps, aimed at autonomously resupplying ground forces. The contract, which spans 18 months, involves creating a prototype medium unmanned logistics system capable of carrying payloads between 300 and 600 pounds over distances from 25 to 100 nautical miles. Key locations for development include Colorado, Ohio, and California. Leidos collaborates with Phenix Solutions for this project. The company reported annual revenues of about $14.4 billion for the fiscal year ending December 30, 2022, enhancing its position as a leader in defense technology.
Summary not available.
Leidos (NYSE: LDOS) has announced a conference call on May 2, 2023, at 8 a.m. ET to discuss its first-quarter 2023 financial results ending March 31, 2023. The earnings press release will precede the call on the same date. Interested parties can listen via a live internet stream or by telephone at 877-869-3847 (U.S.) or +1-201-689-8261 (international). A replay will be available starting at 11:30 a.m. ET on May 2 until May 9. Leidos, headquartered in Reston, Virginia, reported approximately $14.4 billion in revenues for the fiscal year ending December 30, 2022.
Leidos Partnership for Defense Health has successfully deployed the MHS GENESIS electronic health record system to nine additional Military Treatment Facilities, including Walter Reed National Military Medical Center. This deployment impacts 14,000 clinicians and brings the operational count to over 2,700 locations, serving 6.6 million Department of Defense beneficiaries, or approximately 81% of garrison facilities. The deployment continues through 23 waves, aiming for full operational readiness across the continental U.S. and globally. Leidos reported revenues of approximately $14.4 billion for FY 2022, underscoring its leading role in defense health technology.
Leidos announced that 22 of its employees were recognized for excellence in STEM at the 2023 Black Engineer of the Year Awards held in February. The event attracted over 10,000 STEM professionals from diverse backgrounds. Among the honorees, Kendric Garmon received the STEM Professional Most Promising Engineer award, while Randall King and Jordan Thompson won the Science Spectrum Trailblazer award. Additionally, 18 employees were named BEYA Modern Day Technology Leaders, emphasizing the company's commitment to diversity and inclusion in STEM. Leidos takes pride in supporting its employees and fostering talent in these critical fields.
Leidos (NYSE: LDOS) has partnered with the University of Michigan for its $334 million Mayhem program, a hypersonic project awarded by the U.S. Air Force Research Laboratory. This partnership will provide U-M aerospace students with hands-on experience in Model-Based Systems Engineering (MBSE), contributing to the development of a virtual ecosystem for the Mayhem program. Students will gain significant industry experience while helping Leidos enhance efficiencies and drive innovation in aerospace technology. Leidos aims to develop a pipeline of talent through this initiative, creating future leaders in the field.
Summary not available.
Leidos (NYSE: LDOS) will participate in the J.P. Morgan 2023 Industrials Conference on March 15, 2023, from 4:40 p.m. to 5:20 p.m. ET in location value="LU/us.ny.nyc"New York City. CEO Roger Krone will engage in a fireside chat during this event. A live audio webcast will be available on the Leidos Investor Relations website, with a replay accessible for 30 days post-event. Leidos is a FORTUNE 500® leader in technology, engineering, and science solutions, reporting approximately $14.4 billion in revenues for the fiscal year ending December 30, 2022.
RESTON, VA / ACCESSWIRE / March 1, 2023 / Leidos (NYSE:LDOS) announced the appointment of Thomas Bell as Chief Executive Officer, effective May 3, 2023. Bell, currently President of Defense at Rolls-Royce, will succeed Roger Krone, who has led the company since 2014 and will retire at the 2023 annual meeting. The board will also appoint Robert S. Shapard as independent chair post-meeting. Bell's selection followed a thorough process, and his extensive background in defense and aerospace is expected to provide continuity and leadership. Leidos reported approximately $14.4 billion in annual revenues for 2022.
Leidos (NYSE: LDOS) has secured a prime contract and three subcontracts from the Centers for Medicare and Medicaid Services (CMS) valued at approximately $102 million. The prime contract, which totals about $79 million, spans five years and will focus on IT operations and user services. Leidos aims to enhance CMS's mission-critical programs ensuring they remain agile and secure. Services include application migration, modernization, and support for hybrid cloud environments. This win aligns with Leidos’ strategy in IT modernization and could strengthen its market position.